Datasets:

Modalities:
Text
Languages:
English
Libraries:
Datasets
License:
Dataset Viewer
Auto-converted to Parquet Duplicate
id
stringlengths
15
15
document_id
stringlengths
11
11
passages
list
entities
list
events
list
coreferences
list
relations
list
NCT00050349_exc
NCT00050349
[ { "id": "NCT00050349_exc_text", "type": "exclusion", "text": [ "Patients with symptomatic CNS metastases or leptomeningeal involvement \nPatients with known brain metastases, unless these metastases have been treated and/or have been stable for at least six months prior to study start. Subjects wi...
[ { "id": "NCT00050349_exc_T1", "text": [ "CNS metastases" ], "type": "Condition", "offsets": [ [ 26, 40 ] ], "normalized": [] }, { "id": "NCT00050349_exc_T2", "text": [ "leptomeningeal involvement" ], "type": "Condition", "of...
[]
[]
[ { "id": "NCT00050349_exc_R1", "type": "Has_temporal", "arg1_id": "NCT00050349_exc_T6", "arg2_id": "NCT00050349_exc_T7", "normalized": [] }, { "id": "NCT00050349_exc_R3", "type": "AND", "arg1_id": "NCT00050349_exc_T8", "arg2_id": "NCT00050349_exc_T9", "normalized": [] },...
NCT00050349_inc
NCT00050349
[ { "id": "NCT00050349_inc_text", "type": "inclusion", "text": [ "Patients with biopsy-proven metastatic carcinoid tumors or other neuroendocrine tumors (Islet cell, Gastrinomas and VIPomas) with at least one measurable lesion (other than bone) that has either not been previously irradiated or if pr...
[ { "id": "NCT00050349_inc_T1", "text": [ "metastatic carcinoid tumors" ], "type": "Condition", "offsets": [ [ 28, 55 ] ], "normalized": [] }, { "id": "NCT00050349_inc_T2", "text": [ "proven" ], "type": "Value", "offsets": [ ...
[]
[]
[ { "id": "NCT00050349_inc_R1", "type": "Has_value", "arg1_id": "NCT00050349_inc_T3", "arg2_id": "NCT00050349_inc_T2", "normalized": [] }, { "id": "NCT00050349_inc_R2", "type": "AND", "arg1_id": "NCT00050349_inc_T1", "arg2_id": "NCT00050349_inc_T3", "normalized": [] }, ...
NCT00061308_exc
NCT00061308
[ { "id": "NCT00061308_exc_text", "type": "exclusion", "text": [ "Women of child-bearing potential that do not practice adequate contraception. \nPregnant or lactating. \nReceived more than one primary chemotherapy regimen. \nConcomitant or previous malignancies with the exception of adequately trea...
[ { "id": "NCT00061308_exc_T1", "text": [ "Women" ], "type": "Person", "offsets": [ [ 0, 5 ] ], "normalized": [] }, { "id": "NCT00061308_exc_T2", "text": [ "child-bearing potential" ], "type": "Condition", "offsets": [ [...
[]
[]
[ { "id": "NCT00061308_exc_R1", "type": "Has_negation", "arg1_id": "NCT00061308_exc_T4", "arg2_id": "NCT00061308_exc_T3", "normalized": [] }, { "id": "NCT00061308_exc_R2", "type": "AND", "arg1_id": "NCT00061308_exc_T2", "arg2_id": "NCT00061308_exc_T4", "normalized": [] },...
NCT00061308_inc
NCT00061308
[ { "id": "NCT00061308_inc_text", "type": "inclusion", "text": [ "Have had one prior platinum-based chemotherapy regimen for the treatment of primary disease. \nAt least 4 weeks since last surgery or radiation therapy. \nMust have had a treatment-free interval of greater than 6 months following resp...
[ { "id": "NCT00061308_inc_T1", "text": [ "platinum-based chemotherapy regimen" ], "type": "Drug", "offsets": [ [ 19, 54 ] ], "normalized": [] }, { "id": "NCT00061308_inc_T2", "text": [ "primary disease" ], "type": "Condition", ...
[]
[]
[ { "id": "NCT00061308_inc_R1", "type": "AND", "arg1_id": "NCT00061308_inc_T2", "arg2_id": "NCT00061308_inc_T1", "normalized": [] }, { "id": "NCT00061308_inc_R2", "type": "Has_temporal", "arg1_id": "NCT00061308_inc_T1", "arg2_id": "NCT00061308_inc_T3", "normalized": [] },...
NCT00094861_exc
NCT00094861
[ { "id": "NCT00094861_exc_text", "type": "exclusion", "text": [ "Metastatic disease (M1)/stage 4 NSCLC \nPleural or pericardial effusion greater than 100 ml in volume as documented by appropriate imaging (positron emission tomography [PET], computed tomography [CT] scan or ultrasound). If an effusi...
[ { "id": "NCT00094861_exc_T1", "text": [ "Metastatic disease", "NSCLC" ], "type": "Condition", "offsets": [ [ 0, 18 ], [ 32, 37 ] ], "normalized": [] }, { "id": "NCT00094861_exc_T2", "text": [ "(M1)/stag...
[]
[]
[ { "id": "NCT00094861_exc_R1", "type": "Subsumes", "arg1_id": "NCT00094861_exc_T1", "arg2_id": "NCT00094861_exc_T2", "normalized": [] }, { "id": "NCT00094861_exc_R2", "type": "Subsumes", "arg1_id": "NCT00094861_exc_T6", "arg2_id": "NCT00094861_exc_T8", "normalized": [] }...
NCT00094861_inc
NCT00094861
[ { "id": "NCT00094861_inc_text", "type": "inclusion", "text": [ "Patients with a histologically or cytologically proven diagnosis of NSCLC \nUnresectable (locally advanced) stage IIIa or IIIb disease \nInitial radiotherapy field of treatment to encompass greater than or equal to 30% of the esophagu...
[ { "id": "NCT00094861_inc_T1", "text": [ "NSCLC" ], "type": "Condition", "offsets": [ [ 68, 73 ] ], "normalized": [] }, { "id": "NCT00094861_inc_T2", "text": [ "cytologically proven" ], "type": "Qualifier", "offsets": [ ...
[]
[]
[ { "id": "NCT00094861_inc_R1", "type": "Has_scope", "arg1_id": "NCT00094861_inc_T1", "arg2_id": "NCT00094861_inc_T4", "normalized": [] }, { "id": "NCT00094861_inc_R2", "type": "Subsumes", "arg1_id": "NCT00094861_inc_T7", "arg2_id": "NCT00094861_inc_T8", "normalized": [] ...
NCT00122070_exc
NCT00122070
[ { "id": "NCT00122070_exc_text", "type": "exclusion", "text": [ "Are pregnant or lactating. \nHave participated in any other studies involving investigational products within 30 days prior to entry into this study. \nAre undergoing an acute withdrawal syndrome from drugs or alcohol. \nHave an Axis ...
[ { "id": "NCT00122070_exc_T1", "text": [ "pregnant" ], "type": "Condition", "offsets": [ [ 4, 12 ] ], "normalized": [] }, { "id": "NCT00122070_exc_T2", "text": [ "lactating" ], "type": "Condition", "offsets": [ [ ...
[]
[]
[ { "id": "NCT00122070_exc_R1", "type": "Has_index", "arg1_id": "NCT00122070_exc_T4", "arg2_id": "NCT00122070_exc_T5", "normalized": [] }, { "id": "NCT00122070_exc_R2", "type": "Has_temporal", "arg1_id": "NCT00122070_exc_T3", "arg2_id": "NCT00122070_exc_T4", "normalized": [...
NCT00122070_inc
NCT00122070
[ { "id": "NCT00122070_inc_text", "type": "inclusion", "text": [ "Provide written informed consent before beginning any study related activities \nBe between age 18 and 55 years \nBe able to speak, read and write English and follow simple instructions for completing self-rated scales \nMeet DSM-IV c...
[ { "id": "NCT00122070_inc_T2", "text": [ "age" ], "type": "Person", "offsets": [ [ 91, 94 ] ], "normalized": [] }, { "id": "NCT00122070_inc_T3", "text": [ "between", "18 and 55 years" ], "type": "Value", "offsets": [ ...
[]
[]
[ { "id": "NCT00122070_inc_R1", "type": "Has_value", "arg1_id": "NCT00122070_inc_T2", "arg2_id": "NCT00122070_inc_T3", "normalized": [] }, { "id": "NCT00122070_inc_R2", "type": "Has_qualifier", "arg1_id": "NCT00122070_inc_T5", "arg2_id": "NCT00122070_inc_T6", "normalized": ...
NCT00182520_exc
NCT00182520
[ { "id": "NCT00182520_exc_text", "type": "exclusion", "text": [ "Any other primary DSM-IV diagnosis; DSM-IV criteria for body dysmorphic disorder, bipolar affective disorder, schizophrenia, psychotic disorder, current alcohol/substance abuse.\nA previous adequate trial of topiramate\nComorbid major...
[ { "id": "NCT00182520_exc_T1", "text": [ "DSM-IV" ], "type": "Qualifier", "offsets": [ [ 18, 24 ] ], "normalized": [] }, { "id": "NCT00182520_exc_T2", "text": [ "primary" ], "type": "Qualifier", "offsets": [ [ 1...
[]
[]
[ { "id": "NCT00182520_exc_R1", "type": "Has_qualifier", "arg1_id": "NCT00182520_exc_T3", "arg2_id": "NCT00182520_exc_T1", "normalized": [] }, { "id": "NCT00182520_exc_R2", "type": "Has_qualifier", "arg1_id": "NCT00182520_exc_T3", "arg2_id": "NCT00182520_exc_T2", "normalize...
NCT00182520_inc
NCT00182520
[ { "id": "NCT00182520_inc_text", "type": "inclusion", "text": [ "Outpatient with primary DSM- IV OCD\nCompletion of a 14-week open label trial of one the following SRI's: fluoxetine 80 mg/day, paroxetine 60 mg/day, fluvoxamine 300 mg/day, clomipramine 250 mg/day, sertraline 200 mg/day, citalopram 6...
[ { "id": "NCT00182520_inc_T1", "text": [ "OCD" ], "type": "Condition", "offsets": [ [ 32, 35 ] ], "normalized": [] }, { "id": "NCT00182520_inc_T2", "text": [ "primary" ], "type": "Qualifier", "offsets": [ [ 16, ...
[]
[]
[ { "id": "NCT00182520_inc_R1", "type": "Has_qualifier", "arg1_id": "NCT00182520_inc_T1", "arg2_id": "NCT00182520_inc_T3", "normalized": [] }, { "id": "NCT00182520_inc_R2", "type": "Has_qualifier", "arg1_id": "NCT00182520_inc_T1", "arg2_id": "NCT00182520_inc_T2", "normalize...
NCT00183885_exc
NCT00183885
[ { "id": "NCT00183885_exc_text", "type": "exclusion", "text": [ "Patients who have received prior chemotherapy for unresectable disease \nPatients with any active or uncontrolled infection, including known HIV infection. (Patients with active hepatitis B will be placed on lamivudine. Patients with ...
[ { "id": "NCT00183885_exc_T1", "text": [ "chemotherapy" ], "type": "Procedure", "offsets": [ [ 33, 45 ] ], "normalized": [] }, { "id": "NCT00183885_exc_T2", "text": [ "unresectable disease" ], "type": "Condition", "offsets": ...
[]
[]
[ { "id": "NCT00183885_exc_R1", "type": "AND", "arg1_id": "NCT00183885_exc_T1", "arg2_id": "NCT00183885_exc_T2", "normalized": [] }, { "id": "NCT00183885_exc_R2", "type": "Has_scope", "arg1_id": "NCT00183885_exc_T5", "arg2_id": "NCT00183885_exc_T6", "normalized": [] }, ...
NCT00183885_inc
NCT00183885
[ { "id": "NCT00183885_inc_text", "type": "inclusion", "text": [ "Unresectable, histologically confirmed hepatocellular carcinoma with evident disease limited to liver. \nTissue from tumor must be available. This may be paraffin embedded tissue from previous biopsy/resection or if it is not availabl...
[ { "id": "NCT00183885_inc_T1", "text": [ "Unresectable" ], "type": "Qualifier", "offsets": [ [ 0, 12 ] ], "normalized": [] }, { "id": "NCT00183885_inc_T2", "text": [ "hepatocellular carcinoma" ], "type": "Condition", "offsets...
[]
[]
[ { "id": "NCT00183885_inc_R1", "type": "Has_value", "arg1_id": "NCT00183885_inc_T3", "arg2_id": "NCT00183885_inc_T4", "normalized": [] }, { "id": "NCT00183885_inc_R2", "type": "AND", "arg1_id": "NCT00183885_inc_T2", "arg2_id": "NCT00183885_inc_T3", "normalized": [] }, ...
NCT00198913_exc
NCT00198913
[ { "id": "NCT00198913_exc_text", "type": "exclusion", "text": [ "type 1 diabetic or non-diabetic \n \n" ], "offsets": [ [ 0, 44 ] ] } ]
[ { "id": "NCT00198913_exc_T1", "text": [ "type 1 diabetic" ], "type": "Condition", "offsets": [ [ 0, 15 ] ], "normalized": [] }, { "id": "NCT00198913_exc_T2", "text": [ "non-diabetic" ], "type": "Condition", "offsets": [ ...
[]
[]
[]
NCT00198913_inc
NCT00198913
[ { "id": "NCT00198913_inc_text", "type": "inclusion", "text": [ "type 2 diabetic, age 18 and over, informed consent, \n" ], "offsets": [ [ 0, 53 ] ] } ]
[ { "id": "NCT00198913_inc_T1", "text": [ "type 2 diabetic" ], "type": "Condition", "offsets": [ [ 0, 15 ] ], "normalized": [] }, { "id": "NCT00198913_inc_T2", "text": [ "age" ], "type": "Person", "offsets": [ [ ...
[]
[]
[ { "id": "NCT00198913_inc_R1", "type": "Has_value", "arg1_id": "NCT00198913_inc_T2", "arg2_id": "NCT00198913_inc_T3", "normalized": [] } ]
NCT00235170_exc
NCT00235170
[ { "id": "NCT00235170_exc_text", "type": "exclusion", "text": [ "1. Congestive heart failure; \n2. CABG or Percutaneous Coronary Intervention (PCI) procedure; \n3. Planned need for major surgery (e.g. valve surgery or resection of aortic or left ventricular aneurysm, carotid end-arterectomy, abdomi...
[ { "id": "NCT00235170_exc_T1", "text": [ "Congestive heart failure" ], "type": "Condition", "offsets": [ [ 3, 27 ] ], "normalized": [] }, { "id": "NCT00235170_exc_T2", "text": [ "CABG" ], "type": "Procedure", "offsets": [ ...
[]
[]
[ { "id": "NCT00235170_exc_R1", "type": "Has_negation", "arg1_id": "NCT00235170_exc_T15", "arg2_id": "NCT00235170_exc_T14", "normalized": [] }, { "id": "NCT00235170_exc_R2", "type": "Has_value", "arg1_id": "NCT00235170_exc_T13", "arg2_id": "NCT00235170_exc_T15", "normalized...
NCT00235170_inc
NCT00235170
[ { "id": "NCT00235170_inc_text", "type": "inclusion", "text": [ "1. Patients with stable (Canadian Cardiovascular Society 1, 2, 3 or 4) or unstable (Braunwald class IB, IC, IIB, IIC, IIIB, IIIC) angina pectoris and ischemia, or patients with atypical chest pain or even those who are asymptomatic pr...
[ { "id": "NCT00235170_inc_T1", "text": [ "Canadian Cardiovascular Society" ], "type": "Measurement", "offsets": [ [ 25, 56 ] ], "normalized": [] }, { "id": "NCT00235170_inc_T2", "text": [ "1, 2, 3 or 4" ], "type": "Value", "o...
[]
[]
[ { "id": "NCT00235170_inc_R1", "type": "Has_value", "arg1_id": "NCT00235170_inc_T1", "arg2_id": "NCT00235170_inc_T2", "normalized": [] }, { "id": "NCT00235170_inc_R2", "type": "Subsumes", "arg1_id": "NCT00235170_inc_T3", "arg2_id": "NCT00235170_inc_T1", "normalized": [] ...
NCT00236340_exc
NCT00236340
[ { "id": "NCT00236340_exc_text", "type": "exclusion", "text": [ "Multiple pregnancy (more than 3 fetuses) \nMaternal history of placental abruptio \nFetus with IUGR \nPregnancy complicated with pre-eclampsia \nUnability to give informed consent \n \n" ], "offsets": [ [ ...
[ { "id": "NCT00236340_exc_T1", "text": [ "Multiple pregnancy" ], "type": "Condition", "offsets": [ [ 0, 18 ] ], "normalized": [] }, { "id": "NCT00236340_exc_T2", "text": [ "more than 3" ], "type": "Value", "offsets": [ ...
[]
[]
[ { "id": "NCT00236340_exc_R2", "type": "Has_value", "arg1_id": "NCT00236340_exc_T3", "arg2_id": "NCT00236340_exc_T2", "normalized": [] }, { "id": "NCT00236340_exc_R3", "type": "AND", "arg1_id": "NCT00236340_exc_T5", "arg2_id": "NCT00236340_exc_T4", "normalized": [] }, ...
NCT00236340_inc
NCT00236340
[ { "id": "NCT00236340_inc_text", "type": "inclusion", "text": [ "Pregnant women with abdomen discumfort and ultrasound diagnosis of polyhydramnios (AFI>25cm) \nSingle or twin pregnancies \n" ], "offsets": [ [ 0, 122 ] ] } ]
[ { "id": "NCT00236340_inc_T1", "text": [ "Pregnant" ], "type": "Condition", "offsets": [ [ 0, 8 ] ], "normalized": [] }, { "id": "NCT00236340_inc_T2", "text": [ "women" ], "type": "Person", "offsets": [ [ 9, ...
[]
[]
[ { "id": "NCT00236340_inc_R1", "type": "Has_value", "arg1_id": "NCT00236340_inc_T6", "arg2_id": "NCT00236340_inc_T7", "normalized": [] }, { "id": "NCT00236340_inc_R3", "type": "Has_value", "arg1_id": "NCT00236340_inc_T4", "arg2_id": "NCT00236340_inc_T8", "normalized": [] ...
NCT00250640_exc
NCT00250640
[ { "id": "NCT00250640_exc_text", "type": "exclusion", "text": [ "Any condition that prevents participation in the study, including pregnancy and other contraindications for Ventavis treatment (as listed in the current Ventavis Summary of Product Characteristics and patient package insert) \n ...
[ { "id": "NCT00250640_exc_T1", "text": [ "pregnancy" ], "type": "Condition", "offsets": [ [ 66, 75 ] ], "normalized": [] }, { "id": "NCT00250640_exc_T2", "text": [ "contraindications" ], "type": "Condition", "offsets": [ ...
[]
[]
[ { "id": "NCT00250640_exc_R1", "type": "AND", "arg1_id": "NCT00250640_exc_T2", "arg2_id": "NCT00250640_exc_T3", "normalized": [] }, { "id": "NCT00250640_exc_R2", "type": "Subsumes", "arg1_id": "NCT00250640_exc_T2", "arg2_id": "NCT00250640_exc_T4", "normalized": [] } ]
NCT00250640_inc
NCT00250640
[ { "id": "NCT00250640_inc_text", "type": "inclusion", "text": [ "The treating physician has chosen Ventavis as a suitable long-term treatment for the patient \nPatient with primary pulmonary hypertension (i.e. Idiopathic Pulmonary Arterial Hypertension or Familial Pulmonary Arterial Hypertension) a...
[ { "id": "NCT00250640_inc_T1", "text": [ "Ventavis" ], "type": "Drug", "offsets": [ [ 34, 42 ] ], "normalized": [] }, { "id": "NCT00250640_inc_T2", "text": [ "primary pulmonary hypertension" ], "type": "Condition", "offsets":...
[]
[]
[ { "id": "NCT00250640_inc_R1", "type": "Subsumes", "arg1_id": "NCT00250640_inc_T2", "arg2_id": "NCT00250640_inc_T5", "normalized": [] }, { "id": "NCT00250640_inc_R2", "type": "Has_value", "arg1_id": "NCT00250640_inc_T6", "arg2_id": "NCT00250640_inc_T7", "normalized": [] ...
NCT00279552_exc
NCT00279552
[ { "id": "NCT00279552_exc_text", "type": "exclusion", "text": [ "Patients who were pregnant, nursing or not able to give written informed consent were excluded. \n \n" ], "offsets": [ [ 0, 108 ] ] } ]
[ { "id": "NCT00279552_exc_T1", "text": [ "pregnant" ], "type": "Condition", "offsets": [ [ 18, 26 ] ], "normalized": [] }, { "id": "NCT00279552_exc_T2", "text": [ "nursing" ], "type": "Condition", "offsets": [ [ ...
[]
[]
[ { "id": "NCT00279552_exc_R1", "type": "Has_negation", "arg1_id": "NCT00279552_exc_T3", "arg2_id": "NCT00279552_exc_T4", "normalized": [] } ]
NCT00279552_inc
NCT00279552
[ { "id": "NCT00279552_inc_text", "type": "inclusion", "text": [ "Patients suspected to have vitamin B12 deficiency defined as a plasma vitamin B12 below the reference interval (<200 pmol/L). \n" ], "offsets": [ [ 0, 127 ] ] } ]
[ { "id": "NCT00279552_inc_T1", "text": [ "vitamin B12 deficiency" ], "type": "Condition", "offsets": [ [ 27, 49 ] ], "normalized": [] }, { "id": "NCT00279552_inc_T2", "text": [ "suspected" ], "type": "Mood", "offsets": [ ...
[]
[]
[ { "id": "NCT00279552_inc_R1", "type": "Has_mood", "arg1_id": "NCT00279552_inc_T1", "arg2_id": "NCT00279552_inc_T2", "normalized": [] }, { "id": "NCT00279552_inc_R2", "type": "Subsumes", "arg1_id": "NCT00279552_inc_T4", "arg2_id": "NCT00279552_inc_T5", "normalized": [] }...
NCT00305097_exc
NCT00305097
[ { "id": "NCT00305097_exc_text", "type": "exclusion", "text": [ "Any condition/illness that may affect the study outcomes or would make participation potentially harmful such as pregnancy or breastfeeding, diabetes mellitus, heart disease, stroke, hypertension, malabsorption syndromes, GERD, a hist...
[ { "id": "NCT00305097_exc_T1", "text": [ "pregnancy" ], "type": "Condition", "offsets": [ [ 113, 122 ] ], "normalized": [] }, { "id": "NCT00305097_exc_T2", "text": [ "breastfeeding" ], "type": "Observation", "offsets": [ ...
[]
[]
[ { "id": "NCT00305097_exc_R1", "type": "AND", "arg1_id": "NCT00305097_exc_T9", "arg2_id": "NCT00305097_exc_T10", "normalized": [] }, { "id": "NCT00305097_exc_R2", "type": "Subsumes", "arg1_id": "NCT00305097_exc_T14", "arg2_id": "NCT00305097_exc_T13", "normalized": [] }, ...
NCT00305097_inc
NCT00305097
[ { "id": "NCT00305097_inc_text", "type": "inclusion", "text": [ "Aged at least 18 years with an ability and willingness to give written informed consent. \nBody mass index 25-35 kg/m2 \nUsers of at least 2 cups of caffeinated coffee per day who are willing to be randomized to any of the interventio...
[ { "id": "NCT00305097_inc_T1", "text": [ "Aged" ], "type": "Person", "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "NCT00305097_inc_T2", "text": [ "at least 18 years" ], "type": "Value", "offsets": [ [ 5,...
[]
[]
[ { "id": "NCT00305097_inc_R1", "type": "Has_value", "arg1_id": "NCT00305097_inc_T1", "arg2_id": "NCT00305097_inc_T2", "normalized": [] }, { "id": "NCT00305097_inc_R2", "type": "Has_multiplier", "arg1_id": "NCT00305097_inc_T8", "arg2_id": "NCT00305097_inc_T7", "normalized":...
NCT00312429_exc
NCT00312429
[ { "id": "NCT00312429_exc_text", "type": "exclusion", "text": [ "Undergoing Interleukin-2 (IL-2) therapy within 8 weeks of study entry \nDiagnosed with a medical or psychiatric illness that may interfere with study participation \nPregnant \n \n" ], "offsets": [ [ 0, ...
[ { "id": "NCT00312429_exc_T1", "text": [ "Interleukin-2 (IL-2) therapy" ], "type": "Procedure", "offsets": [ [ 11, 39 ] ], "normalized": [] }, { "id": "NCT00312429_exc_T2", "text": [ "within 8 weeks of study entry" ], "type": "Te...
[]
[]
[ { "id": "NCT00312429_exc_R1", "type": "Has_temporal", "arg1_id": "NCT00312429_exc_T1", "arg2_id": "NCT00312429_exc_T2", "normalized": [] } ]
NCT00312429_inc
NCT00312429
[ { "id": "NCT00312429_inc_text", "type": "inclusion", "text": [ "Diagnosis reviewed at transplant center and confirmed to fit the criterion for high risk blood disease or cancer, as defined for the study \nEstimated life expectancy of at least 6 weeks following study entry \nCancer and Leukemia Gro...
[ { "id": "NCT00312429_inc_T1", "text": [ "high risk blood disease" ], "type": "Condition", "offsets": [ [ 79, 102 ] ], "normalized": [] }, { "id": "NCT00312429_inc_T2", "text": [ "cancer" ], "type": "Condition", "offsets": [ ...
[]
[]
[ { "id": "NCT00312429_inc_R1", "type": "Has_value", "arg1_id": "NCT00312429_inc_T3", "arg2_id": "NCT00312429_inc_T4", "normalized": [] }, { "id": "NCT00312429_inc_R2", "type": "Has_value", "arg1_id": "NCT00312429_inc_T5", "arg2_id": "NCT00312429_inc_T8", "normalized": [] ...
NCT00317148_exc
NCT00317148
[ { "id": "NCT00317148_exc_text", "type": "exclusion", "text": [ "Body mass index (BMI) of 35 kg/m2 or more. \nSignificant metabolic and endocrine diseases. \nDiagnosis of cancer. \nUse of steroids or drugs that interfere with the metabolism of estrogen. \nUse of any systemic estrogen, progestin, or...
[ { "id": "NCT00317148_exc_T1", "text": [ "Body mass index (BMI)" ], "type": "Measurement", "offsets": [ [ 0, 21 ] ], "normalized": [] }, { "id": "NCT00317148_exc_T2", "text": [ "35 kg/m2 or more" ], "type": "Value", "offsets"...
[]
[]
[ { "id": "NCT00317148_exc_R1", "type": "Has_value", "arg1_id": "NCT00317148_exc_T1", "arg2_id": "NCT00317148_exc_T2", "normalized": [] }, { "id": "NCT00317148_exc_R2", "type": "Has_temporal", "arg1_id": "NCT00317148_exc_T12", "arg2_id": "NCT00317148_exc_T11", "normalized":...
NCT00317148_inc
NCT00317148
[ { "id": "NCT00317148_inc_text", "type": "inclusion", "text": [ "Healthy postmenopausal women with 50 or more moderate to severe hot flushes. \nWomen between 40 to 70 years of age. \n" ], "offsets": [ [ 0, 116 ] ] } ]
[ { "id": "NCT00317148_inc_T1", "text": [ "postmenopausal" ], "type": "Condition", "offsets": [ [ 8, 22 ] ], "normalized": [] }, { "id": "NCT00317148_inc_T2", "text": [ "Healthy" ], "type": "Condition", "offsets": [ [ ...
[]
[]
[ { "id": "NCT00317148_inc_R1", "type": "AND", "arg1_id": "NCT00317148_inc_T4", "arg2_id": "NCT00317148_inc_T5", "normalized": [] }, { "id": "NCT00317148_inc_R2", "type": "Has_value", "arg1_id": "NCT00317148_inc_T8", "arg2_id": "NCT00317148_inc_T7", "normalized": [] } ]
NCT00319748_exc
NCT00319748
[ { "id": "NCT00319748_exc_text", "type": "exclusion", "text": [ "Had/have the following prior/concurrent therapy: \nSystemic corticosteroids (oral or injectable) within 7 days of first dose of 852A (topical or inhaled steroids are allowed) \nInvestigational drugs/agents within 14 days of first dose...
[ { "id": "NCT00319748_exc_T1", "text": [ "Systemic corticosteroids" ], "type": "Drug", "offsets": [ [ 50, 74 ] ], "normalized": [] }, { "id": "NCT00319748_exc_T2", "text": [ "within 7 days of first dose" ], "type": "Temporal", ...
[]
[]
[ { "id": "NCT00319748_exc_R1", "type": "Has_temporal", "arg1_id": "NCT00319748_exc_T1", "arg2_id": "NCT00319748_exc_T2", "normalized": [] }, { "id": "NCT00319748_exc_R2", "type": "AND", "arg1_id": "NCT00319748_exc_T2", "arg2_id": "NCT00319748_exc_T3", "normalized": [] },...
End of preview. Expand in Data Studio

Dataset Card for CHIA

A large annotated corpus of patient eligibility criteria extracted from 1,000 interventional, Phase IV clinical trials registered in ClinicalTrials.gov. This dataset includes 12,409 annotated eligibility criteria, represented by 41,487 distinctive entities of 15 entity types and 25,017 relationships of 12 relationship types.

Citation Information

@article{kury2020chia,
  title        = {Chia, a large annotated corpus of clinical trial eligibility criteria},
  author       = {
    Kury, Fabr{'\i}cio and Butler, Alex and Yuan, Chi and Fu, Li-heng and
    Sun, Yingcheng and Liu, Hao and Sim, Ida and Carini, Simona and Weng,
    Chunhua
  },
  year         = 2020,
  journal      = {Scientific data},
  publisher    = {Nature Publishing Group},
  volume       = 7,
  number       = 1,
  pages        = {1--11}
}
Downloads last month
164